The Cooper Companies COO announced the opening of The Vision Centre, a new global innovation hub in Southampton, England, for its CooperVision business, alongside six product advancements spanning myopia control, silicone hydrogel, toric and multifocal contact lenses with launches planned over the next several years. The Vision Centre is designed to bring research and development, clinical expertise, pilot manufacturing, advanced technologies and commercial capabilities under one facility, supporting research, clinical studies, product development and new product introduction programs. CooperVision's accelerated pipeline includes a complete family of 1-day contact lenses for myopia control, a premium 1-day silicone hydrogel technology, a next-generation silicone hydrogel material for monthly contact lenses, a 1-day silicone hydrogel product aimed at expanding fits, a 1-day silicone hydrogel toric multifocal lens and a new toric 1-day lens experience for patients with astigmatism. CooperVision's products currently reach more than 40 million people worldwide, and the company expects to provide further updates on its product pipeline going forward. Following the announcement, COO stock gained 1.4% at yesterday's close, though shares have declined 31.6% year to date against the industry's 2.8% growth and the S&P 500's 12% gain, leaving a market capitalization of $10.51 billion.
Globus Medical
Intuitive Surgical IncThe Cooper Companies, IncCooperVision opened a new global innovation hub and unveiled six contact-lens product advancements across myopia control, silicone hydrogel, toric and multifocal lenses.
Veracyte Inc
